Acrylamide induces immediate-early gene expression in rat brain

[1]  P. Spencer,et al.  Effect of acrylamide on the distribution of microtubule-associated proteins (MAP1 and MAP2) in selected regions of rat brain. , 1993, Molecular and chemical neuropathology.

[2]  P. Spencer,et al.  Acrylamide-induced depletion of microtubule-associated proteins (MAP1 and MAP2) in the rat extrapyramidal system , 1993, Brain Research.

[3]  F. Sharp,et al.  N-methyl-d-aspartate receptor activation in the neostriatum increases c-fos and fos-related antigens selectively in medium-sized neurons , 1991, Neuroscience.

[4]  R. Bravo,et al.  Selective expression of Jun proteins following axotomy and axonal transport block in peripheral nerves in the rat: evidence for a role in the regeneration process , 1991, Brain Research.

[5]  S. Hunt,et al.  Long-term increase in the levels of c-jun mRNA and jun protein-like immunoreactivity in motor and sensory neurons following axon damage , 1991, Neuroscience Letters.

[6]  F R Sharp,et al.  c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  D. W. Sickles.  Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport. , 1991, Neurotoxicology.

[8]  A. Gunn,et al.  Effects of hypoxia-ischemia and seizures on neuronal and glial-like c-fos protein levels in the infant rat , 1990, Brain Research.

[9]  K. Jeffery,et al.  Induction of Fos-like immunoreactivity and the maintenance of long-term potentiation in the dentate gyrus of unanesthetized rats. , 1990, Brain research. Molecular brain research.

[10]  S. R. Fowler,et al.  Effects of neurofilamentous axonopathy-producing neurotoxicants on in vitro production of ATP by brain mitochondria , 1990, Brain Research.

[11]  R. Faull,et al.  Induction of Fos in glia-like cells after focal brain injury but not during wallerian degeneration , 1990, Brain Research.

[12]  F. Sharp,et al.  c-fos proto-oncogene expression in astrocytes associated with differentiation or proliferation but not depolarization. , 1990, Brain research. Molecular brain research.

[13]  J. Séquier,et al.  Mast cell degranulating peptide induces the expression of the c-fos proto-oncogene in hippocampus. , 1990, European Journal of Pharmacology.

[14]  M. Greenberg,et al.  The regulation and function of c-fos and other immediate early genes in the nervous system , 1990, Neuron.

[15]  R. Faull,et al.  Induction of c-fos mRNA and protein in neurons and glia after traumatic brain injury: Pharmacological characterization , 1990, Experimental Neurology.

[16]  James I. Morgan,et al.  Stimulus-transcription coupling in neurons: role of cellular immediate-early genes , 1989, Trends in Neurosciences.

[17]  T. Curran,et al.  Regulation of proenkephalin by Fos and Jun. , 1989, Science.

[18]  H. Herschman,et al.  Extracellular signals, transcriptional responses and cellular specificity. , 1989, Trends in biochemical sciences.

[19]  Manuel F. Gonzalez,et al.  Induction of the c-fos gene product in rat forebrain following cortical lesions and NGF injections , 1989, Neuroscience Letters.

[20]  J. Deckert,et al.  Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study , 1989, Brain Research.

[21]  B. Franza,et al.  Fos and jun: The AP-1 connection , 1988, Cell.

[22]  I. Verma,et al.  Induction of proto-oncogene JUN/AP-1 by serum and TPA , 1988, Nature.

[23]  T. Curran,et al.  Expression of c-fos protein in brain: metabolic mapping at the cellular level. , 1988, Science.

[24]  M. Dragunow,et al.  Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus , 1987, Nature.

[25]  T. Curran,et al.  Mapping patterns of c-fos expression in the central nervous system after seizure. , 1987, Science.

[26]  D. Price,et al.  Neurofilament Antigens in Acrylamide Neuropathy , 1987, Journal of neuropathology and experimental neurology.

[27]  D. Price,et al.  Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  P. Spencer,et al.  Single Doses of Acrylamide Reduce Retrograde Transport Velocity , 1984, Journal of neurochemistry.

[29]  Michael E. Greenberg,et al.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene , 1984, Nature.

[30]  T. Mandybur,et al.  Effects of acrylamide on locomotion and central monoamine function in the rat , 1983, Pharmacology Biochemistry and Behavior.

[31]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[32]  J. Cavanagh.  THE PATHOKINETICS OF ACRYLAMIDE INTOXICATION: A REASSESSMENT OF THE PROBLEM , 1982, Neuropathology and applied neurobiology.

[33]  J. Cavanagh,et al.  ULTRASTRUCTUAL CHANGES IN AXONS CAUSED BY ACRYLAMIDE ABOVE A NERVE LIGATURE , 1981, Neuropathology and applied neurobiology.

[34]  S. D. Murphy,et al.  Effect of acrylamide intoxication on pyridine nucleotide concentrations and functions in rat cerebral cortex. , 1977, Biochemical pharmacology.

[35]  P. Spencer,et al.  Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. , 1977, Journal of neuropathology and experimental neurology.

[36]  Y. Kawamura,et al.  Acrylamide encephaloneuropathy due to well water pollution. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[37]  H. Schaumburg,et al.  A Review of Acrylamide Neurotoxicity Part II. Experimental Animal Neurotoxicity and Pathologic Mechanisms , 1974, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[38]  P. Spencer,et al.  A Review of Acrylamide Neurotoxicity Part I. Properties, Uses and Human Exposure , 1974, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[39]  H. Wiśniewski,et al.  ULTRASTRUCTURAL STUDIES OF THE DYING‐BACK PROCESS: 1. PERIPHERAL NERVE TERMINAL AND AXON DEGENERATION IS SYSTEMIC ACRYLAMIDE INTOXICATION , 1974, Journal of neuropathology and experimental neurology.

[40]  J. Prineas.  THE PATHOGENESIS OF DYING‐BACK POLYNEUROPATHIES: PART II. AN ULTRASTRUCTURAL STUDY of EXPERIMENTAL ACRYLAMIDE INTOXICATION in the CAT , 1969, Journal of neuropathology and experimental neurology.

[41]  P. Fullerton.  Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man. , 1969, Journal of neurology, neurosurgery, and psychiatry.

[42]  T. Garland,et al.  Six cases of acrylamide poisoning. , 1967, British medical journal.

[43]  J. Barnes,et al.  Peripheral Neuropathy in Rats Produced by Acrylamide , 1966, British journal of industrial medicine.

[44]  T. Curran,et al.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc , 1984, Nature.

[45]  Jonathan A. Cooper,et al.  Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein , 1984, Nature.